- List
- By Topic
- On Map
- Search Details

Recruiting, Not yet recruiting, Available Studies | "Breast Neoplasms"
Need help? See RSS Feeds
Choose a feed type:

Recruiting, Not yet recruiting, Available Studies | "Breast Neoplasms" (2073 records)
Need help? See Downloading Content for Analysis
For Advanced Users: Full Study Record XML Download
1 | NCT03024463 | Recruiting | The Validation Study of Internal Mammary Lymph Biopsy in Breast Cancer Patients |
|
|
Observational |
|
Other |
|
|
200 | Female | 18 Years to 70 Years (Adult, Senior) | NCT03024463 | IMLN-VS | August 1, 2017 | March 1, 2019 | August 1, 2019 | January 18, 2017 | March 20, 2018 |
|
|||
2 | NCT02489448 | Recruiting | Neoadjuvant MEDI4736 Concomitant With Weekly Nab-paclitaxel and Dose-dense AC for Stage I-III Triple Negative Breast Cancer |
|
|
Interventional | Phase 1 Phase 2 |
|
Other |
|
|
61 | All | 18 Years and older (Adult, Senior) | NCT02489448 | 1409014537 | November 2015 | October 2018 | October 2019 | July 3, 2015 | October 25, 2017 |
|
||
3 | NCT02258451 | Recruiting | Study of Radium-223 Dichloride Versus Placebo and Treatment With Exemestane / Everolimus in Subjects With Bone Predominant HER2 (Human Epidermal Growth Factor Receptor 2) Negative Hormone Receptor Positive Metastatic Breast Cancer |
|
|
Interventional | Phase 2 |
|
Industry |
|
|
311 | Female | 18 Years and older (Adult, Senior) | NCT02258451 | 17096 2014-002114-23 |
June 4, 2015 | August 31, 2018 | March 15, 2019 | October 7, 2014 | April 13, 2018 |
|
||
4 | NCT02834494 | Recruiting | Assessment of Response to Neo-adjuvant Chemotherapy for Patients With a Locally Advanced Breast Cancer With 3D Elastography (Shear Wave), |
|
|
Interventional | Not Applicable |
|
Other |
|
|
140 | All | 18 Years and older (Adult, Senior) | NCT02834494 | IC 2015-07 | NEO-ELASTO | February 2016 | October 2018 | October 2018 | July 15, 2016 | July 13, 2017 |
|
|
5 | NCT02776917 | Not yet recruiting | Study of Cirmtuzumab and Paclitaxel for Metastatic or Locally Advanced, Unresectable Breast Cancer |
|
|
Interventional | Phase 1 |
|
Other |
|
|
12 | All | 18 Years and older (Adult, Senior) | NCT02776917 | 160178 | January 2018 | January 2019 | January 2020 | May 18, 2016 | May 12, 2017 |
|
||
6 | NCT02948764 | Recruiting | Diagnosis of Pathological Complete Response by Vacuum-assisted Biopsy After Neoadjuvant Chemotherapy in Breast Cancer |
|
|
Interventional | Not Applicable |
|
Other |
|
|
600 | Female | 18 Years and older (Adult, Senior) | NCT02948764 | 2 | RESPONDER | January 2017 | September 2018 | December 2019 | October 28, 2016 | March 31, 2017 |
|
|
7 | NCT02781259 | Recruiting | Selective Lymph Node Dissection Using Fluorescent Dye in Node-positive Breast Cancer |
|
|
Interventional | Phase 4 |
|
Other |
|
|
150 | Female | 20 Years to 70 Years (Adult, Senior) | NCT02781259 | 2015-01-046-007 | May 2016 | February 2017 | April 2017 | May 24, 2016 | September 20, 2016 |
|
||
8 | NCT02774473 | Recruiting | [18F]Fluorothymidine (FLT) PET/CT Imaging In Rb+ Metastatic Breast Cancer Patients Undergoing LEE011 And Weekly Paclitaxel Therapy |
|
|
Interventional | Not Applicable |
|
Other |
|
|
20 | All | 18 Years and older (Adult, Senior) | NCT02774473 | UPCC 11115 | February 2016 | February 2020 | May 17, 2016 | July 31, 2017 |
|
|||
9 | NCT03277898 | Not yet recruiting | Aerobic Exercise and Cognitive Functioning in Women With Breast Cancer |
|
|
Interventional | Not Applicable |
|
Other |
|
|
84 | Female | 19 Years to 65 Years (Adult) | NCT03277898 | H17-00563 | ACTIVATE | November 1, 2017 | November 1, 2019 | November 1, 2020 | September 11, 2017 | September 11, 2017 |
|
|
10 | NCT03069742 | Recruiting | Study of Web-based Decision Aids for Increasing Breast Cancer Chemoprevention in the Primary Care Setting |
|
|
Interventional | Not Applicable |
|
Other / NIH |
|
|
350 | Female | 35 Years to 75 Years (Adult, Senior) | NCT03069742 | AAAP4151 II R01CA177995 |
November 2016 | April 2019 | April 2019 | March 3, 2017 | May 11, 2017 |
|
||
11 | NCT03250676 | Recruiting | Trial of H3B-6545, a Covalent Antagonist of Estrogen Receptor Alpha, in Women With Locally Advanced or Metastatic Estrogen Receptor-positive, HER2 Negative Breast Cancer |
|
|
Interventional | Phase 1 Phase 2 |
|
Industry |
|
|
110 | Female | 18 Years and older (Adult, Senior) | NCT03250676 | H3B-6545-A001-101 BRE 287 |
August 18, 2017 | December 2018 | April 2019 | August 16, 2017 | December 20, 2017 |
|
||
12 | NCT03389204 | Not yet recruiting | Upper Limb Function After Breast Cancer Surgery: the Role of Post-operative Physical Therapy Intervention |
|
Observational |
|
Other |
|
|
1200 | Female | 18 Years to 65 Years (Adult) | NCT03389204 | AMC2020-17 | April 1, 2018 | July 1, 2019 | September 1, 2019 | January 3, 2018 | February 13, 2018 |
|
||||
13 | NCT03272477 | Recruiting | Study to Compare Neoadjuvant Combination of Trastuzumab and Pertuzumab With Concurrent Taxane Chemotherapy or Endocrine Therapy and Quality of Life Assessment Under Adjuvant Therapy in Operable HER2+/HR+ Breast Cancer Patients |
|
|
Interventional | Phase 2 |
|
Industry / Other |
|
|
259 | Female | 18 Years and older (Adult, Senior) | NCT03272477 | PH002-TP-II | TP-II | August 22, 2017 | March 15, 2020 | November 15, 2024 | September 5, 2017 | September 20, 2017 |
|
|
14 | NCT03310957 | Recruiting | Safety and Efficacy of SGN-LIV1A Plus Pembrolizumab for Patients With Locally-Advanced or Metastatic Triple-Negative Breast Cancer |
|
|
Interventional | Phase 1 Phase 2 |
|
Industry |
|
|
72 | All | 18 Years and older (Adult, Senior) | NCT03310957 | SGNLVA-002 KEYNOTE 721 |
February 27, 2018 | May 2020 | May 2020 | October 16, 2017 | April 3, 2018 |
|
||
15 | NCT03283384 | Not yet recruiting | Tailoring NEOadjuvant Therapy in Hormone Receptor Positive, HER2 Negative, Luminal Breast Cancer. |
|
|
Interventional | Phase 2 |
|
Other / Industry |
|
|
100 | Female | 18 Years and older (Adult, Senior) | NCT03283384 | BOOG-2017-01 2017-000676-29 |
NEOLBC | February 2018 | July 2020 | February 2025 | September 14, 2017 | February 6, 2018 |
|
|
16 | NCT03323346 | Recruiting | Phase II Trial of Disulfiram With Copper in Metastatic Breast Cancer |
|
|
Interventional | Phase 2 |
|
Other |
|
|
150 | Female | 18 Years and older (Adult, Senior) | NCT03323346 | 2016-1-DSF-MBC | DISC | September 29, 2017 | December 31, 2019 | September 30, 2020 | October 27, 2017 | October 27, 2017 |
|
|
17 | NCT03275727 | Not yet recruiting | A Guided Internet-delivered Individually-tailored ACT-influenced CBT Intervention to Improve Psychosocial Outcomes in Breast Cancer |
|
|
Interventional | Phase 2 Phase 3 |
|
Other |
|
|
128 | Female | 18 Years and older (Adult, Senior) | NCT03275727 | INNOVBC | INNOVBC | February 2018 | December 2019 | December 2019 | September 8, 2017 | September 8, 2017 | ||
18 | NCT02480842 | Recruiting | Clinical Trial With Two Physical Therapy Protocols After Breast Cancer Surgery and Immediate Reconstruction |
|
|
Interventional | Not Applicable |
|
Other |
|
|
120 | Female | 18 Years and older (Adult, Senior) | NCT02480842 | FUSaoPaulo PT 3 | June 2015 | June 2018 | June 25, 2015 | June 29, 2015 |
|
|||
19 | NCT02744079 | Not yet recruiting | Comparison of Healthy Diets on Breast Cancer Markers |
|
|
Interventional | Not Applicable |
|
Other |
|
|
65 | Female | 21 Years and older (Adult, Senior) | NCT02744079 | 2016-6346 | KetoBreast | February 20, 2018 | September 2019 | September 2020 | April 20, 2016 | January 11, 2018 |
|
|
20 | NCT03423199 | Recruiting | PAlbociclib Plus Tamoxifen for the Treatment of Hormone Receptor-positive, HER2-negative Advanced Breast Cancer Women - Asian studY |
|
|
Interventional | Phase 3 |
|
Other / Industry |
|
|
180 | Female | 18 Years and older (Adult, Senior) | NCT03423199 | NCCH1607 WI217662 |
PATHWAY | February 9, 2018 | February 2022 | February 2022 | February 6, 2018 | April 3, 2018 |
|
|
21 | NCT03284567 | Recruiting | Football Fitness After Breast Cancer |
|
|
Interventional | Not Applicable |
|
Other |
|
|
90 | Female | 18 Years to 75 Years (Adult, Senior) | NCT03284567 | FFABC | FFABC | March 20, 2017 | April 30, 2019 | April 30, 2019 | September 15, 2017 | September 15, 2017 |
|
|
22 | NCT03220178 | Recruiting | Impact of eHealth-support on Quality of Life in Metastatic Breast Cancer Patients Treated With Palbociclib and Endocrine Therapy |
|
|
Interventional | Phase 4 |
|
Industry / Other |
|
|
960 | Female | 18 Years and older (Adult, Senior) | NCT03220178 | PH001-PreCycle | PRECYCLE | June 20, 2017 | June 30, 2021 | December 31, 2023 | July 18, 2017 | April 24, 2018 |
|
|
23 | NCT02065960 | Recruiting | Feasibility Study of Stereotactic Body Radiotherapy for Early Breast Cancer |
|
|
Interventional | Phase 1 |
|
Other |
|
|
32 | Female | 70 Years and older (Senior) | NCT02065960 | 13-699 | ARTEMIS | February 2014 | June 2016 | June 2020 | February 19, 2014 | March 31, 2015 |
|
|
24 | NCT03447132 | Recruiting | Fulvestrant Versus Fulvestrant Plus Palbociclib in Operable Breast Cancer Responding to Fulvestrant |
|
|
Interventional | Phase 3 |
|
Other / Industry |
|
|
400 | Female | 18 Years and older (Adult, Senior) | NCT03447132 | ICRG1201 | SAFIA | January 1, 2018 | September 1, 2023 | September 1, 2023 | February 27, 2018 | February 27, 2018 |
|
|
25 | NCT01176916 | Recruiting | Aromasin® Non-Interventional Study Of Early Invasive Breast Cancer Patients In China |
|
|
Interventional | Phase 4 |
|
Industry |
|
|
550 | Female | Child, Adult, Senior | NCT01176916 | A5991093 NRA5990043 |
February 9, 2011 | December 1, 2018 | December 1, 2018 | August 6, 2010 | April 18, 2018 |
|
||
26 | NCT03242551 | Recruiting | Biomarkers Investigation of Neoadjuvant Chemotherapy for Breast Cancer |
|
|
Interventional | Phase 2 |
|
Other |
|
|
120 | Female | 18 Years to 70 Years (Adult, Senior) | NCT03242551 | Shenzhen BC-001 | BINC-B | November 8, 2017 | August 31, 2022 | December 31, 2022 | August 8, 2017 | November 14, 2017 |
|
|
27 | NCT03039127 | Recruiting | Immunostimulating Interstitial Laser Thermotherapy in Breast Cancer |
|
|
Interventional | Not Applicable |
|
Industry / Other |
|
|
5 | All | Child, Adult, Senior | NCT03039127 | CTP-2015-009 | June 2016 | February 2018 | August 2018 | February 1, 2017 | February 2, 2017 |
|
||
28 | NCT03269981 | Recruiting | Randomized Study of Elective Regional Lymph Node Irradiation in N1 Breast Cancer |
|
|
Interventional | Not Applicable |
|
Other |
|
|
1926 | Female | 20 Years to 70 Years (Adult, Senior) | NCT03269981 | SMC 2017-01-085-001 | April 1, 2017 | March 30, 2021 | March 30, 2023 | September 1, 2017 | September 1, 2017 |
|
||
29 | NCT03242616 | Recruiting | PemVin vs Vin in Previously Treated Metastatic Breast Cancer |
|
|
Interventional | Phase 2 |
|
Other |
|
|
125 | All | 20 Years and older (Adult, Senior) | NCT03242616 | H1607-172-780 | February 17, 2017 | December 31, 2019 | December 31, 2019 | August 8, 2017 | August 8, 2017 |
|
||
30 | NCT03266562 | Recruiting | Estrogen Receptor Expression in Breast Cancer - Assessed With Positron Emission Mammography |
|
|
Interventional | Not Applicable |
|
Other |
|
|
20 | Female | 40 Years to 90 Years (Adult, Senior) | NCT03266562 | 16-007764 | PEM-FES | April 1, 2018 | April 2019 | December 2019 | August 30, 2017 | March 21, 2018 |
|
|
31 | NCT02781805 | Recruiting | Pilot Study of Bisphosphonates for Breast Cancer |
|
|
Interventional | Phase 1 |
|
Other / NIH |
|
|
20 | Female | 18 Years and older (Adult, Senior) | NCT02781805 | UW13060 P30CA014520 2016-0322 |
August 2016 | January 1, 2019 | August 1, 2019 | May 24, 2016 | February 22, 2018 |
|
||
32 | NCT02866994 | Recruiting | Project Connect Online: An Internet-based Intervention for Women With Breast Cancer |
|
|
Interventional | Not Applicable |
|
Other / NIH |
|
|
64 | Female | 18 Years and older (Adult, Senior) | NCT02866994 | 14-001744 20155036 SAC110009 |
PCO | June 4, 2015 | December 31, 2018 | December 31, 2019 | August 15, 2016 | November 14, 2017 |
|
|
33 | NCT03024580 | Recruiting | A Study Evaluating Megestrol Acetate Modulation in Hormone Receptor Positive Advanced Breast Cancer |
|
|
Interventional | Phase 2 |
|
Other |
|
|
20 | Female | Child, Adult, Senior | NCT03024580 | 64/16 | MEGA | March 6, 2017 | March 2018 | September 2018 | January 19, 2017 | December 6, 2017 |
|
|
34 | NCT02547545 | Recruiting | Breast Cancer Chemotherapy Risk Prediction Mathematical Model |
|
Observational |
|
Other |
|
|
795 | Female | 18 Years to 80 Years (Adult, Senior) | NCT02547545 | XJTU1AF2012LSK-021 | BCCRPMM | September 2015 | March 2017 | May 2017 | September 11, 2015 | August 10, 2016 |
|
|||
35 | NCT03273426 | Recruiting | Prediction of pCR by Preoperative Biopsy in Breast Cancer With cCR After Neoadjuvant Chemotherapy. |
|
|
Interventional | Not Applicable |
|
Other |
|
|
40 | Female | 18 Years to 80 Years (Adult, Senior) | NCT03273426 | SNUHBCC002 | September 8, 2016 | October 2017 | December 2017 | September 6, 2017 | September 6, 2017 |
|
||
36 | NCT02491957 | Recruiting | Impact of LOFT Therapy™ on Breast Cancer Survivors |
|
|
Interventional | Not Applicable |
|
Other |
|
|
15 | All | 18 Years and older (Adult, Senior) | NCT02491957 | IUSCC-0539 | July 28, 2015 | March 29, 2018 | March 29, 2019 | July 8, 2015 | June 2, 2017 |
|
||
37 | NCT03124095 | Recruiting | Combined Training Intervention for Women Who Underwent Primary Treatment for Breast Cancer |
|
|
Interventional | Not Applicable |
|
Other |
|
|
42 | Female | 18 Years and older (Adult, Senior) | NCT03124095 | +Vida-Breast cancer | +Vida | September 2016 | July 2017 | December 2017 | April 21, 2017 | April 21, 2017 |
|
|
38 | NCT02938442 | Not yet recruiting | Vaccination of Triple Negative Breast Cancer Patients |
|
|
Interventional | Phase 2 |
|
Other |
|
|
102 | Female | 18 Years and older (Adult, Senior) | NCT02938442 | 206010 | October 2018 | November 2020 | November 2020 | October 19, 2016 | November 9, 2017 |
|
||
39 | NCT03202862 | Not yet recruiting | The Efficacy of Fulvestrant in ESR1(Estrogen Receptor 1) Mutated Metastatic Breast Cancer |
|
|
Interventional | Phase 2 |
|
Other |
|
|
50 | Female | Child, Adult, Senior | NCT03202862 | Fulvestrant in ESR1 Mutated BC | July 1, 2017 | June 1, 2019 | August 1, 2019 | June 29, 2017 | June 29, 2017 | |||
40 | NCT02982564 | Recruiting | Effect of Low vs Moderate-intensity Endurance Exercise on Physical Functioning Among Breast Cancer Survivors |
|
|
Interventional | Not Applicable |
|
Other |
|
|
142 | Female | 50 Years and older (Adult, Senior) | NCT02982564 | 1SC3GM116684-01 | March 2016 | February 2020 | February 2020 | December 5, 2016 | June 7, 2017 |
|
||
41 | NCT02819882 | Recruiting | A Prospective Registry Study in Patients With Unresectable Locally Advanced or Metastatic Breast Cancer (MBC) |
|
|
Observational |
|
Other / Industry |
|
|
1400 | All | 18 Years and older (Adult, Senior) | NCT02819882 | GEICAM 2014-03 | REGISTEM | June 2016 | June 2024 | June 2024 | June 30, 2016 | January 11, 2018 |
|
||
42 | NCT02898727 | Recruiting | A Study of Local Therapy for the Treatment of Brain Metastases From HER2 Positive Breast Cancer |
|
|
Interventional | Phase 2 |
|
Other |
|
|
50 | All | 18 Years and older (Adult, Senior) | NCT02898727 | TROG 16.02 | Local HER-O | November 20, 2017 | May 2020 | May 2020 | September 13, 2016 | February 28, 2018 |
|
|
43 | NCT02740491 | Recruiting | Implementation of a "Remission" Consultation in the Management of Patients Treated for Localized Breast Cancer |
|
|
Observational |
|
Other |
|
|
50 | Female | 18 Years and older (Adult, Senior) | NCT02740491 | LOCAL/2016/LD-01 | REVIS | September 2016 | September 2018 | September 2018 | April 15, 2016 | November 1, 2017 |
|
||
44 | NCT03280563 | Recruiting | A Study of Multiple Immunotherapy-Based Treatment Combinations in Hormone Receptor (HR)-Positive Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Breast Cancer |
|
|
Interventional | Phase 1 Phase 2 |
|
Industry |
|
|
111 | Female | 18 Years and older (Adult, Senior) | NCT03280563 | CO39611 2017-000335-14 |
MORPHEUS | September 30, 2017 | April 30, 2021 | October 7, 2022 | September 12, 2017 | April 13, 2018 |
|
|
45 | NCT02316561 | Recruiting | Single Dose Ablative Radiation Treatment for Early-Stage Breast Cancer |
|
|
Interventional | Not Applicable |
|
Other |
|
|
25 | Female | 50 Years and older (Adult, Senior) | NCT02316561 | NL46017.041.13 | ABLATIVE | October 2014 | May 2018 | May 2028 | December 15, 2014 | January 20, 2017 |
|
|
46 | NCT02718144 | Recruiting | Assessment of Safety and Efficacy of Estetrol in Postmenopausal Women With Advanced Estrogen Receptor Positive (ER+) Breast Cancer |
|
|
Interventional | Phase 1 Phase 2 |
|
Other |
|
|
18 | Female | Child, Adult, Senior | NCT02718144 | PR3106 | June 1, 2017 | October 2018 | October 2018 | March 24, 2016 | March 30, 2018 |
|
||
47 | NCT02934815 | Recruiting | Relational and Emotional Mechanisms of a Supportive-expressive Group Intervention in Breast Cancer |
|
|
Interventional | Not Applicable |
|
Other |
|
|
50 | Female | 30 Years to 65 Years (Adult) | NCT02934815 | FPCEUP/BreastCancerCare | BC-SEGT | January 2015 | January 2017 | January 2017 | October 17, 2016 | October 17, 2016 |
|
|
48 | NCT02756364 | Recruiting | MLN0128 in Combination With Fulvestrant in Women With Advanced or Metastatic Breast Cancer After Aromatase Inhibitor Therapy |
|
|
Interventional | Phase 2 |
|
Industry |
|
|
153 | Female | 18 Years and older (Adult, Senior) | NCT02756364 | C31006 2015-003612-20 U1111-1174-2165 |
June 1, 2016 | May 1, 2018 | May 1, 2018 | April 29, 2016 | March 26, 2018 |
|
||
49 | NCT02271828 | Recruiting | Omitting Sentinel Node Procedure in Breast Cancer Patients Undergoing Breast Conserving Therapy |
|
|
Interventional | Not Applicable |
|
Other |
|
|
1644 | Female | 18 Years and older (Adult, Senior) | NCT02271828 | BOOG 2013-08 KWF UM 2014-6679 |
April 2015 | April 2027 | April 2027 | October 22, 2014 | April 21, 2017 |
|
||
50 | NCT02620735 | Recruiting | Smart-phone Health Coaching Intervention to Promote Maintenance of Exercise in Breast Cancer Survivors:Protocol |
|
|
Interventional | Not Applicable |
|
Other |
|
|
107 | Female | 18 Years to 75 Years (Adult, Senior) | NCT02620735 | 13-6157-DE | iMOVE | December 2014 | December 2016 | July 2017 | December 3, 2015 | August 9, 2016 |
|
† Study has passed its completion date and status has not been verified in more than two years.